BackgroundIn times of increasing global challenges to health, it is crucial to create a workforce capable of tackling these complex issues. Even though a lack of GHE in Germany is perceived by multiple stakeholders, no systematic analysis of the current landscape exists. The aim of this study is to provide an analysis of the global health education (GHE) capacity in Germany as well as to identify gaps, barriers and future strategies.MethodsAn online search in combination with information provided by student representatives, course coordinators and lecturers was used to create an overview of the current GHE landscape in Germany. Additionally, a semi-structured questionnaire was sent to GHE educators and students engaged in global health (GH) to assess the capacity of German GHE, its barriers and suggested strategies for the future.ResultsA total of 33 GHE activities were identified at 18 German universities. Even though medical schools are the main provider of GHE (42%), out of 38 medical schools, only 13 (34%) offer any kind of GHE. Modules offered for students of other health-related professions constitute 27% of all activities. Most survey respondents (92%, n = 48) consider current GHE activities in Germany insufficient. Suggested formats were GHE as part of medical curricula (82%, n = 45) and dual degree MD/MPH or PhD programs. Most important barriers mentioned were low priority of GH at faculties and academic management levels (n = 41, 75%) as well as lack of necessary institutional structures (n = 33, 60%).ConclusionsDespite some innovative academic approaches, there is clearly a need for more systematic GHE in Germany. GHE educators and students can take an important role advocating for more awareness at university management level and suggesting ways to institutionalize GHE to overcome barriers. This study provides key evidence, relevant perceptions and suggestions to strengthen GHE in Germany.
Aims and objectives The aim of this study was to identify and analyse factors influencing the use of drugs for dementia treatment in home care settings. Background While the number of care‐dependent people with dementia is growing, it is not clear whether their medication follows the state of the art, especially in home care settings where over two‐thirds of them are cared for in Germany. Although dementia is not curable, it is possible to reduce cognitive, behavioural and psychological symptoms of dementia with the appropriate use of medication. However, there is a lack of information concerning the drug treatment in home care settings. Methods The study was conducted as a multicentre cross‐sectional survey, including 923 participants from 102 home care institutions throughout Germany. Medical diagnosis, medication, consultations with a specialist within the previous 12 weeks of the initial assessment and additional general information were assessed following a standardised study protocol. Data were analysed using univariate and multivariate statistical methods. The manuscript was developed utilising the STROBE checklist for cross‐sectional studies. Results In home care, one in seven clients (14.8%) is diagnosed with some form of dementia. 52.6% (n = 72) of them were treated with dementia medication: AchEIs 16.1% (n = 22), memantine 9.5% (n = 13), antidepressants 23.4% (n = 32), antipsychotic medication 9.5% (n = 13), tranquilisers 16.8% (n = 23) and anticonvulsant drugs 6.6% (n = 9). Drug treatment for dementia was significantly associated with the consultation of a neurologist/psychiatrist in the previous 12 weeks. Conclusions It has been demonstrated that the use of drugs as a component of home care treatment for dementia depends on many factors and therefore varies. Relevance to clinical practice It can be assumed that people living with dementia in home care settings are not sufficiently supplied with medication. Their medical care can be improved by establishing interdisciplinary care involving a neurologist/psychiatrist.
Zusammenfassung Hintergrund Gewalt gegen pflegebedürftige ältere Menschen ist häufig. Hausärzte/-ärztinnen können bei der Prävention von Gewalt eine Rolle spielen. Insbesondere sexualisierte Gewalt ist stark tabuisiert und wenig untersucht. Ziel der Arbeit Ziel dieser Arbeit ist es, die Einstellung von Hausärzten/-ärztinnen zu ihrer Verantwortung bei sexuellem Missbrauch pflegebedürftiger Patienten/Patientinnen zu untersuchen. Zugleich sollen die subjektive Sicherheit hinsichtlich des Vorgehens bei einem Missbrauchsverdacht sowie die Fortbildungsinteressen von Hausärzten/-ärztinnen zum Thema erhoben werden. Material und Methoden In einer Querschnittsstudie wurden 1700 Hausärzte/-ärztinnen in Deutschland zwischen September und November 2016 schriftlich befragt. Fragebogen von 302 Ärzten/Ärztinnen konnten ausgewertet werden. Ergebnisse Die Unsicherheit hinsichtlich des weiteren Vorgehens bei Verdacht auf sexuellen Missbrauch von pflegebedürftigen Patienten/Patientinnen ist groß. Nahezu alle Befragten sehen es als Teil der ärztlichen Verantwortung, bei sexuellem Missbrauch pflegebedürftiger Patienten/Patientinnen zu intervenieren. Hauptsächliches Fortbildungsinteresse besteht zur Differenzialdiagnose des sexuellen Missbrauchs sowie zum richtigen Vorgehen im Verdachtsfall. Schlussfolgerung Fortbildungen, insbesondere zu den Anzeichen sexueller Gewalt gegen Pflegebedürftige, können einen Beitrag leisten, die Handlungssicherheit von Hausärzten/-ärztinnen zu stärken und ihre Bereitschaft zur Prävention zu erhöhen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.